Sima Lev - Publications

Affiliations: 
Weizmann Institute of Science, Rehovot, Israel 
Area:
Cell signaling, Membrane trafficking, Cancer biology

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Vinik Y, Maimon A, Dubey V, Raj H, Abramovitch I, Malitsky S, Itkin M, Ma'ayan A, Westermann F, Gottlieb E, Ruppin E, Lev S. Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2307263. PMID 38441406 DOI: 10.1002/advs.202307263  0.576
2023 Gil-Henn H, Girault JA, Lev S. PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology. PMID 37586982 DOI: 10.1016/j.tcb.2023.07.006  0.607
2022 Nataraj NB, Noronha A, Lee JS, Ghosh S, Mohan Raju HR, Sekar A, Zuckerman B, Lindzen M, Tarcitano E, Srivastava S, Selitrennik M, Livneh I, Drago-Garcia D, Rueda O, Caldas C, ... Lev S, et al. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Reports. 38: 110418. PMID 35196484 DOI: 10.1016/j.celrep.2022.110418  0.713
2022 Müller AK, Köhler UA, Trzebanski S, Vinik Y, Raj HM, Girault JA, Ben-Chetrit N, Maraver A, Jung S, Lev S. Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2105696. PMID 35092356 DOI: 10.1002/advs.202105696  0.567
2021 Castellanet O, Ahmad F, Vinik Y, Mills GB, Habermann B, Borg JP, Lev S, Lamballe F, Maina F. BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators. Theranostics. 11: 9180-9197. PMID 34646365 DOI: 10.7150/thno.60503  0.66
2021 Khera L, Lev S. Accelerating AXL targeting for TNBC therapy. The International Journal of Biochemistry & Cell Biology. 106057. PMID 34403827 DOI: 10.1016/j.biocel.2021.106057  0.581
2021 Khera L, Vinik Y, Maina F, Lev S. The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC. Life Science Alliance. 4. PMID 33785524 DOI: 10.26508/lsa.202000985  0.592
2021 Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Müller AK, Köhler UA, Bailly AL, Josselin E, Castellano R, Cayrou C, Charafe-Jauffret E, Mills GB, Géli V, Borg JP, ... Lev S, et al. Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2003049. PMID 33552868 DOI: 10.1002/advs.202003049  0.632
2020 Vinik Y, Ortega FG, Mills GB, Lu Y, Jurkowicz M, Halperin S, Aharoni M, Gutman M, Lev S. Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response. Science Advances. 6. PMID 33008904 DOI: 10.1126/sciadv.aba5714  0.625
2020 Verma N, Vinik Y, Saroha A, Nair NU, Ruppin E, Mills G, Karn T, Dubey V, Khera L, Raj H, Maina F, Lev S. Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science Advances. 6. PMID 32937365 DOI: 10.1126/Sciadv.Aba8968  0.619
2020 Shatz-Azoulay H, Vinik Y, Isaac R, Kohler U, Lev S, Zick Y. The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice. Scientific Reports. 10: 7375. PMID 32355198 DOI: 10.1038/S41598-020-64371-Z  0.568
2020 Lev S. Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochemical Society Transactions. 48: 657-665. PMID 32311020 DOI: 10.1042/BST20191055  0.561
2020 Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis. Cancer Research. 80: 362. PMID 31941679 DOI: 10.1158/0008-5472.CAN-19-3573  0.6
2020 Cockcroft S, Lev S. Mammalian PITPs at the Golgi and ER-Golgi Membrane Contact Sites Contact. 3: 251525642096417. DOI: 10.1177/2515256420964170  0.32
2019 Peretti D, Kim S, Tufi R, Lev S. Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer. Frontiers in Cell and Developmental Biology. 7: 371. PMID 32039198 DOI: 10.3389/Fcell.2019.00371  0.616
2019 Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. Correction: The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis (doi:10.1242/jcs.155721). Journal of Cell Science. 132. PMID 30846603 DOI: 10.1242/Jcs.227868  0.57
2018 Kedan A, Verma N, Saroha A, Shreberk-Shaked M, Müller AK, Nair NU, Lev S. PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death & Disease. 9: 985. PMID 30250159 DOI: 10.1038/S41419-018-1005-Z  0.65
2018 Shin SY, Müller AK, Verma N, Lev S, Nguyen LK. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer. Plos Computational Biology. 14: e1006192. PMID 29920512 DOI: 10.1371/Journal.Pcbi.1006192  0.588
2017 Panayotopoulou EG, Müller AK, Börries M, Busch H, Hu G, Lev S. Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. Oncotarget. PMID 28187446 DOI: 10.18632/oncotarget.15125  0.572
2016 Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X, Hu G. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nature Communications. 7: 13884. PMID 27996004 DOI: 10.1038/ncomms13884  0.57
2016 Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis. Cancer Research. PMID 27793840 DOI: 10.1158/0008-5472.Can-16-1797  0.665
2016 Selitrennik M, Lev S. The role of phosphatidylinositol-transfer proteins at membrane contact sites. Biochemical Society Transactions. 44: 419-24. PMID 27068949 DOI: 10.1042/BST20150182  0.63
2015 Selitrennik M, Lev S. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop. Oncotarget. 6: 22214-26. PMID 26084289 DOI: 10.18632/oncotarget.4257  0.599
2015 Verma N, Keinan O, Selitrennik M, Karn T, Filipits M, Lev S. PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition. Nature Communications. 6: 6064. PMID 25648557 DOI: 10.1038/Ncomms7064  0.628
2014 Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis. Journal of Cell Science. 127: 4740-9. PMID 25179602 DOI: 10.1242/Jcs.155721  0.591
2014 Hong W, Lev S. Tethering the assembly of SNARE complexes. Trends in Cell Biology. 24: 35-43. PMID 24119662 DOI: 10.1016/j.tcb.2013.09.006  0.629
2013 Kim S, Kedan A, Marom M, Gavert N, Keinan O, Selitrennik M, Laufman O, Lev S. The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. Embo Reports. 14: 891-9. PMID 23897088 DOI: 10.1038/Embor.2013.113  0.792
2013 Laufman O, Freeze HH, Hong W, Lev S. Deficiency of the Cog8 subunit in normal and CDG-derived cells impairs the assembly of the COG and Golgi SNARE complexes. Traffic (Copenhagen, Denmark). 14: 1065-77. PMID 23865579 DOI: 10.1111/Tra.12093  0.773
2013 Laufman O, Hong W, Lev S. The COG complex interacts with multiple Golgi SNAREs and enhances fusogenic assembly of SNARE complexes. Journal of Cell Science. 126: 1506-16. PMID 23378023 DOI: 10.1242/Jcs.122101  0.782
2012 Rao M, Song W, Jiang A, Shyr Y, Lev S, Greenstein D, Brantley-Sieders D, Chen J. VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. Plos One. 7: e46281. PMID 23049696 DOI: 10.1371/Journal.Pone.0046281  0.596
2012 Lev S. Nonvesicular lipid transfer from the endoplasmic reticulum. Cold Spring Harbor Perspectives in Biology. 4. PMID 23028121 DOI: 10.1101/cshperspect.a013300  0.594
2011 Laufman O, Hong W, Lev S. The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport. The Journal of Cell Biology. 194: 459-72. PMID 21807881 DOI: 10.1083/Jcb.201102045  0.79
2010 Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nature Reviews. Molecular Cell Biology. 11: 739-50. PMID 20823909 DOI: 10.1038/nrm2971  0.594
2010 Kim S, Leal SS, Ben Halevy D, Gomes CM, Lev S. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. The Journal of Biological Chemistry. 285: 13839-49. PMID 20207736 DOI: 10.1074/Jbc.M109.097345  0.575
2009 Laufman O, Kedan A, Hong W, Lev S. Direct interaction between the COG complex and the SM protein, Sly1, is required for Golgi SNARE pairing. The Embo Journal. 28: 2006-17. PMID 19536132 DOI: 10.1038/Emboj.2009.168  0.792
2008 Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature. 455: 242-5. PMID 18690214 DOI: 10.1038/Nature07207  0.566
2008 Peretti D, Dahan N, Shimoni E, Hirschberg K, Lev S. Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Molecular Biology of the Cell. 19: 3871-84. PMID 18614794 DOI: 10.1091/Mbc.E08-05-0498  0.792
2008 Lev S, Ben Halevy D, Peretti D, Dahan N. The VAP protein family: from cellular functions to motor neuron disease. Trends in Cell Biology. 18: 282-90. PMID 18468439 DOI: 10.1016/J.Tcb.2008.03.006  0.779
2006 Lev S. Lipid homoeostasis and Golgi secretory function Biochemical Society Transactions. 34: 363-366. PMID 16709162 DOI: 10.1042/BST0340363  0.614
2005 Litvak V, Dahan N, Ramachandran S, Sabanay H, Lev S. Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function. Nature Cell Biology. 7: 225-34. PMID 15723057 DOI: 10.1038/Ncb1221  0.794
2005 Amarilio R, Ramachandran S, Sabanay H, Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. The Journal of Biological Chemistry. 280: 5934-44. PMID 15545272 DOI: 10.1074/jbc.M409566200  0.603
2005 Corvol JC, Valjent E, Toutant M, Enslen H, Irinopoulou T, Lev S, Hervé D, Girault JA. Depolarization activates ERK and proline-rich tyrosine kinase 2 (PYK2) independently in different cellular compartments in hippocampal slices. The Journal of Biological Chemistry. 280: 660-8. PMID 15537634 DOI: 10.1074/jbc.M411312200  0.626
2004 Rolls A, Avidan H, Cahalon L, Schori H, Bakalash S, Litvak V, Lev S, Lider O, Schwartz M. A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice. The European Journal of Neuroscience. 20: 1973-83. PMID 15450076 DOI: 10.1111/J.1460-9568.2004.03676.X  0.682
2004 Lev S. The role of the Nir/rdgB protein family in membrane trafficking and cytoskeleton remodeling. Experimental Cell Research. 297: 1-10. PMID 15194420 DOI: 10.1016/j.yexcr.2004.02.033  0.631
2004 Litvak V, Argov R, Dahan N, Ramachandran S, Amarilio R, Shainskaya A, Lev S. Mitotic phosphorylation of the peripheral Golgi protein Nir2 by Cdk1 provides a docking mechanism for Plk1 and affects cytokinesis completion. Molecular Cell. 14: 319-30. PMID 15125835 DOI: 10.1016/S1097-2765(04)00214-X  0.789
2003 Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Current Biology : Cb. 13: 297-307. PMID 12593795 DOI: 10.1016/S0960-9822(03)00053-8  0.793
2002 Litvak V, Shaul YD, Shulewitz M, Amarilio R, Carmon S, Lev S. Targeting of Nir2 to lipid droplets is regulated by a specific threonine residue within its PI-transfer domain. Current Biology : Cb. 12: 1513-8. PMID 12225667 DOI: 10.1016/S0960-9822(02)01107-7  0.719
2002 Litvak V, Tian D, Carmon S, Lev S. Nir2, a human homolog of Drosophila melanogaster retinal degeneration B protein, is essential for cytokinesis. Molecular and Cellular Biology. 22: 5064-75. PMID 12077336 DOI: 10.1128/Mcb.22.14.5064-5075.2002  0.74
2002 Tian D, Lev S. Cellular and developmental distribution of human homologues of the Drosophilia rdgB protein in the rat retina. Investigative Ophthalmology & Visual Science. 43: 1946-53. PMID 12037004  0.528
2002 Tian D, Litvak V, Toledo-Rodriguez M, Carmon S, Lev S. Nir2, a novel regulator of cell morphogenesis. Molecular and Cellular Biology. 22: 2650-62. PMID 11909959 DOI: 10.1128/Mcb.22.8.2650-2662.2002  0.731
2001 Lev S. Molecular aspects of retinal degenerative diseases Cellular and Molecular Neurobiology. 21: 575-589. PMID 12043834 DOI: 10.1023/A:1015183500719  0.516
2000 Tian D, Litvak V, Lev S. Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 6478-87. PMID 10964954 DOI: 10.1523/Jneurosci.20-17-06478.2000  0.715
2000 Litvak V, Tian D, Shaul YD, Lev S. Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades. The Journal of Biological Chemistry. 275: 32736-46. PMID 10915788 DOI: 10.1074/Jbc.M004200200  0.752
2000 Ling S, Woronuk G, Sy L, Lev S, Braun AP. Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of Src tyrosine kinase. The Journal of Biological Chemistry. 275: 30683-9. PMID 10893418 DOI: 10.1074/Jbc.M004292200  0.573
1999 Lev S, Hernandez J, Martinez R, Chen A, Plowman G, Schlessinger J.. Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol.. 19: 2278-88.. PMID 10022914 DOI: 10.1128/mcb.19.3.2278  0.628
1997 Qian D, Lev S, van Oers NS, Dikic I, Schlessinger J, Weiss A. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. The Journal of Experimental Medicine. 185: 1253-9. PMID 9104812 DOI: 10.1084/Jem.185.7.1253  0.697
1997 Qian D, Lev S, van Oers NS, Dikic I, Schlessinger J, Weiss A.. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J Exp Med.. 185: 1253-9.. PMID 9104812 DOI: 10.1084/jem.185.7.1253  0.315
1996 Tokiwa G, Dikic I, Lev S, Schlessinger J.. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science.. 273: 1253-9. PMID 9104812 DOI: 10.1084/jem.185.7.1253  0.323
1996 Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 383: 547-50. PMID 8849729 DOI: 10.1038/383547A0  0.771
1996 Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J.. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 383: 547-50. PMID 8849729 DOI: 10.1038/383547a0  0.311
1996 Tokiwa G, Dikic I, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science (New York, N.Y.). 273: 792-4. PMID 8670418 DOI: 10.1126/Science.273.5276.792  0.764
1995 Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 376: 737-45. PMID 7544443 DOI: 10.1038/376737A0  0.699
1995 Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y.. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell. 80: 103-113. PMID 7529140 DOI: 10.1016/0092-8674(95)90455-7  0.728
1994 Lev S, Blechman JM, Givol D, Yarden Y.. Steel factor and c-kit protooncogene: genetic lessons in signal transduction. Crit Rev Oncog.. 5: 141-68. PMID 7531500 DOI: 10.1615/critrevoncog.v5.i2-3.30  0.761
1993 Blechman JM, Lev S, Givol D, Yarden Y.. Structure-function analyses of the kit receptor for the steel factor. Stem Cells.. 12-21. PMID 7691317 DOI: 10.1002/stem.5530110804  0.74
1993 Lev S, Blechman J, Nishikawa S, Givol D, Yarden Y.. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Mol Cell Biol.. 13: 2224-34.. PMID 7681144 DOI: 10.1128/mcb.13.4.2224  0.712
1992 Lev S, Givol D, Yarden Y.. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. Proc Natl Acad Sci U S a.. 89: 678-82. PMID 1370584 DOI: 10.1073/pnas.89.2.678  0.757
1991 Lev S, Givol D, Yarden Y. A specific combination of substrates is involved in signal transduction by the kit-encoded receptor Embo Journal. 10: 647-654. PMID 1705885 DOI: 10.1002/J.1460-2075.1991.Tb07993.X  0.751
1991 Lev S, Givol D, Yarden Y.. A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. Embo J.. 10: 647-54.. PMID 1705885  0.321
1990 Lev S, Yarden Y, Givol D.. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene. Mol Cell Biol.. 10: 6064-8.. PMID 1700279 DOI: 10.1128/mcb.10.11.6064  0.738
Show low-probability matches.